Phase 2 Small Cell Lung Cancer ( SCLC ) Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Small Cell Lung Cancer ( SCLC )

Bindu R Potugari35 enrolled1 locationNCT07339059

Recruiting

Phase 2

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Lung NeoplasmsSmall Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+3 more

Pfizer40 enrolled3 locationsNCT07476287

Recruiting

Phase 1Phase 2

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Colorectal CarcinomaBladder CancerSolid Tumor Malignancies+2 more

Tasca Therapeutics150 enrolled13 locationsNCT07030257